Literature DB >> 16168931

Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study.

Elias Olafsson1, Petur Ludvigsson, Gunnar Gudmundsson, Dale Hesdorffer, Olafur Kjartansson, W Allen Hauser.   

Abstract

BACKGROUND: No population-based incidence studies of epilepsy have studied syndrome classification from the outset. We prospectively studied the incidence of a single unprovoked seizure and epilepsy in the population of Iceland, and applied the syndrome classification endorsed by the International League Against Epilepsy to this population.
METHODS: We used a nationwide surveillance system to prospectively identify all residents of Iceland who presented with a first diagnosis of a single unprovoked seizure or epilepsy between December 1995 and February 1999. All cases were classified by seizure type, cause or risk factors, and epilepsy syndrome.
RESULTS: The mean annual incidence of first unprovoked seizures was 56.8 per 100,000 person-years, 23.5 per 100,000 person-years for single unprovoked seizures, and 33.3 per 100,000 person-years for epilepsy (recurrent unprovoked seizures). Incidence was similar in males and females. Partial seizures occurred in 40% and a putative cause was identified in 33%. Age-specific incidence was highest in the first year of life (130 per 100,000 person-years) and in those 65 years and older (110.5 per 100,000 person-years). Using strict diagnostic criteria for epilepsy syndromes, 58% of cases fell into non-informative categories. Idiopathic epilepsy syndromes were identified in 14% of all cases.
INTERPRETATION: Findings are consistent with incidence studies from developed countries. Although the epilepsy syndrome classification might be useful in tertiary epilepsy centers, it has limited practicality in population studies and for use by general neurologists.

Entities:  

Mesh:

Year:  2005        PMID: 16168931     DOI: 10.1016/S1474-4422(05)70172-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  82 in total

Review 1.  Seizures and epilepsy in Alzheimer's disease.

Authors:  Daniel Friedman; Lawrence S Honig; Nikolaos Scarmeas
Journal:  CNS Neurosci Ther       Date:  2011-06-07       Impact factor: 5.243

Review 2.  Concise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem Cells.

Authors:  Andrew M Tidball; Jack M Parent
Journal:  Stem Cells       Date:  2015-09-15       Impact factor: 6.277

Review 3.  Current Concepts of Memory Disorder in Epilepsy: Edging Towards a Network Account.

Authors:  Genevieve Rayner; Chris Tailby
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

Review 4.  [Clinical features, diagnosis, and treatment of dysphoric states and psychoses associated with epilepsy].

Authors:  H-B Rothenhäusler
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

5.  Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Maria Sudell; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-06-24

Review 6.  The descriptive epidemiology of epilepsy-a review.

Authors:  Poonam Nina Banerjee; David Filippi; W Allen Hauser
Journal:  Epilepsy Res       Date:  2009-04-15       Impact factor: 3.045

Review 7.  [Epileptic seizures and epilepsy after a stroke : Incidence, prevention and treatment].

Authors:  F Benninger; M Holtkamp
Journal:  Nervenarzt       Date:  2017-10       Impact factor: 1.214

Review 8.  Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-07-31

9.  Incidence of epilepsy in Ferrara, Italy.

Authors:  Edward Cesnik; Francesco Pedelini; Raffaella Faggioli; Vincenza Cinzia Monetti; Enrico Granieri; Ilaria Casetta
Journal:  Neurol Sci       Date:  2013-04-26       Impact factor: 3.307

10.  Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case-Control Analysis Using the Clinical Practice Research Datalink.

Authors:  Marlene Bloechliger; Alessandro Ceschi; Stephan Rüegg; Hugo Kupferschmidt; Stephan Kraehenbuehl; Susan S Jick; Christoph R Meier; Michael Bodmer
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.